Yukiko Takatsu1, Naoki Hiki2,3, Souya Nunobe1, Manabu Ohashi1, Michitaka Honda1, Toshiharu Yamaguchi1, Toshifusa Nakajima1, Takeshi Sano1. 1. Department of Gastroenterological Surgery, Cancer Institute Ariake Hospital of JFCR, Tokyo, Japan. 2. Department of Gastroenterological Surgery, Cancer Institute Ariake Hospital of JFCR, Tokyo, Japan. naoki.hiki@jfcr.or.jp. 3. Department of Gastroenterological Surgery, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-10-6 Ariake, Koto-ku, Tokyo, 135-8550, Japan. naoki.hiki@jfcr.or.jp.
Abstract
BACKGROUND: Early-onset gastric cancer is relatively rare. To evaluate the clinicopathological features and surgical outcome of young patients with gastric cancer, this retrospective comparative study was conducted. METHODS: From 2000 to 2010, 4882 patients underwent surgery for gastric adenocarcinoma in our institution. A total of 136 patients under 40 years old were enrolled as the young group, and a total of 1435 patients aged between 60 and 69 were identified as the control group for this study. The patient's characteristics, pathological findings, surgical and clinical outcomes were reviewed, and the risk factors of recurrence were compared between the two groups. RESULTS: Among the young group, patients had significantly fewer comorbidities and postoperative complications. The patient proportion having 7 or more lymph node metastases was higher in the young group (25 %) than in the control group (16 %). The presence of lymph node metastasis was identified as a strong risk factor for recurrence (odds ratio = 4.31) in the young group according to the results of the step-wise logistic regression analysis. Although the disease-specific survival at stage II was relatively better in the young group (p = 0.0439) than in the control group, there were no significant differences in overall survival for all stages. CONCLUSION: Early-onset gastric cancer is likely to present lymph node metastases. The survival rate of gastric cancer in young patients was equivalent to that in patients in their 60s, which is the typical age at onset.
BACKGROUND: Early-onset gastric cancer is relatively rare. To evaluate the clinicopathological features and surgical outcome of young patients with gastric cancer, this retrospective comparative study was conducted. METHODS: From 2000 to 2010, 4882 patients underwent surgery for gastric adenocarcinoma in our institution. A total of 136 patients under 40 years old were enrolled as the young group, and a total of 1435 patients aged between 60 and 69 were identified as the control group for this study. The patient's characteristics, pathological findings, surgical and clinical outcomes were reviewed, and the risk factors of recurrence were compared between the two groups. RESULTS: Among the young group, patients had significantly fewer comorbidities and postoperative complications. The patient proportion having 7 or more lymph node metastases was higher in the young group (25 %) than in the control group (16 %). The presence of lymph node metastasis was identified as a strong risk factor for recurrence (odds ratio = 4.31) in the young group according to the results of the step-wise logistic regression analysis. Although the disease-specific survival at stage II was relatively better in the young group (p = 0.0439) than in the control group, there were no significant differences in overall survival for all stages. CONCLUSION: Early-onset gastric cancer is likely to present lymph node metastases. The survival rate of gastric cancer in young patients was equivalent to that in patients in their 60s, which is the typical age at onset.
Entities:
Keywords:
Gastrectomy; Gastric cancer; Risk factor; Young patients
Authors: C Caldas; F Carneiro; H T Lynch; J Yokota; G L Wiesner; S M Powell; F R Lewis; D G Huntsman; P D Pharoah; J A Jankowski; P MacLeod; H Vogelsang; G Keller; K G Park; F M Richards; E R Maher; S A Gayther; C Oliveira; N Grehan; D Wight; R Seruca; F Roviello; B A Ponder; C E Jackson Journal: J Med Genet Date: 1999-12 Impact factor: 6.318
Authors: Andronik Kapiev; Igor Rabin; Ron Lavy; Bar Chikman; Zahar Shapira; Hasan Kais; Natan Poluksht; Yaron Amsalam; Zvi Halpern; Ilia Markon; Ilan Wassermann; Ariel Halevy Journal: Isr Med Assoc J Date: 2010-12 Impact factor: 0.892
Authors: C W Schildberg; R Croner; V Schellerer; W Haupt; F W Schildberg; M Schildberg; W Hohenberger; T Horbach Journal: Adv Med Sci Date: 2012 Impact factor: 3.287
Authors: D G Huntsman; F Carneiro; F R Lewis; P M MacLeod; A Hayashi; K G Monaghan; R Maung; R Seruca; C E Jackson; C Caldas Journal: N Engl J Med Date: 2001-06-21 Impact factor: 91.245
Authors: Fátima Carneiro; David G Huntsman; Thomas C Smyrk; David A Owen; Raquel Seruca; Paul Pharoah; Carlos Caldas; Manuel Sobrinho-Simões Journal: J Pathol Date: 2004-06 Impact factor: 7.996
Authors: Jan Kulig; Tadeusz Popiela; Piotr Kolodziejczyk; Marek Sierzega; Joanna Jedrys; Antoni M Szczepanik Journal: Langenbecks Arch Surg Date: 2007-07-06 Impact factor: 3.445
Authors: Nabil P Rizk; Peter B Bach; Deborah Schrag; Manjit S Bains; Alan D Turnbull; Martin Karpeh; Murray F Brennan; Valerie W Rusch Journal: J Am Coll Surg Date: 2004-01 Impact factor: 6.113
Authors: Małgorzata Skierucha; Anya Na Milne; G Johan A Offerhaus; Wojciech P Polkowski; Ryszard Maciejewski; Robert Sitarz Journal: World J Gastroenterol Date: 2016-02-28 Impact factor: 5.742
Authors: Zhenqiang Sun; Qisan Wang; Xianbo Yu; Chunlin Ou; Lizhong Yao; Kun Liu; Lin Liu; Lei Ge; Fa Fang; Zeliang Zhao; Haijiang Wang Journal: Int J Clin Exp Med Date: 2015-11-15